People With Severe Diabetes Are Cured in Small Trial of New Drug

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

News
Boston Faces Identity Crisis Amid Trump’s Cuts to University and Research Funding

Colleges and teaching hospitals are the cornerstones of the city’s economy — and identity. But federal funding cuts to higher education could change that.

News
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

News